Open AccessEffectiveness and safety of weekly paclitaxel and cetuximab as a salvage chemotherapy following immune checkpoint inhibitors for recurrent or metastatic head and neck squamous cell carcinoma: A multicenter clinical study
Author(s) -
Takahiro Wakasaki,
Tomomi Manako,
Ryuji Yasumatsu,
Hirotaka Hara,
Satoshi Toh,
Munetaka Masuda,
Masao Yamauchi,
Yuichiro Kuratomi,
Emi K. Nishimura,
Toranoshin Takeuchi,
Masaki Matsuo,
Rina Jiromaru,
Kazuki Hashimoto,
Noritaka Komune,
Takashi Nakagawa
Publication year - 2022
Publication title -
plos one
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.99
H-Index - 332
ISSN - 1932-6203
DOI - 10.1371/journal.pone.0271907
Subject(s) - medicine , cetuximab , oncology , head and neck squamous cell carcinoma , chemotherapy , adverse effect , salvage therapy , incidence (geometry) , head and neck cancer , radiation therapy , cancer , physics , colorectal cancer , optics